It is not too often that you see a patent application filed for treatment before a disease is even identified but that is exactly what appears to be happening with CV19. On January 21 2020, the Wuhan Institute of Virology applied for a Chinese “use patent” on remdesivir, for the novel use of treating COVID-19.  Barmann, Jay. “Bay Area-Based Gilead […]